Question 1

What are the potential side effects of 68Ga-PSMA-0057 and 177Lu-PSMA-0057?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer clinical trial (NCT07310355). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer clinical trial (NCT07310355). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the participation process look like, including visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer clinical trial (NCT07310355). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the eligibility criteria, and do I meet them?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer clinical trial (NCT07310355). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer clinical trial (NCT07310355). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer clinical trial (NCT07310355). Contact the study team or your healthcare provider for specific answers.

What this study is about